Upadacitinib and Filgotinib: The Role of JAK1 Selective Inhibition in the Treatment of Rheumatoid Arthritis
Drugs in Context - United Kingdom
doi 10.7573/dic.212595
Full Text
Open PDFAbstract
Available in full text
Date
October 24, 2019
Authors
Publisher
BioExcel